Molecular structure and antioxidant specificity of purpurogallin in three types of human cardiovascular cells.
Purpurogallin (PPG) in an active cytoprotector found in certain oak barks. We have shown that PPG prolongs the survival of cultured cardiocytes from rats and rabbits against different oxidants better than do antioxidants such as Trolox (a hydrophilic analogue of vitamin E) in a morphometric assay system. First, we verified by X-ray crystallography that PPG is a bicyclic molecule comprising a phenolic ring fused with a seven-membered ring in a highly planar conformation. In analogues of PPG wherein the two double bonds in the seven membered ring of the parent molecule are saturated or where the four OH groups of the parent compound are substituted by four OCH3 groups, the derivatives are less planar and less protective of the human cells than native PPG. Second, PPG in a concentration-dependent manner protected myocytes and endothelial cells of humans against oxyradicals generated with any one of the following oxyradical generators: (a) xanthine oxidase plus hypoxanthine, (b) menadione, or (c) paraquat. In each case, PPG was more cytoprotective than comparative antioxidants. Also, PPG protected erythrocytes against peroxyl radicals better than the two PPG derivatives mentioned. Third, the cytoprotective action of PPG detected in vitro was accompanied by declines of malondialdehyde. Finally, we observed that PPG chelated ferrous ions and, therefore, can suppress the formation of radicals in the Fenton reaction. Thus, PPG with its molecular architecture and presumably its affinity for ferrous ions protects multiple types of cardiovascular cells against oxyradicals.
Wu
T W
TW
Centre of Cardiovascular Research, University of Toronto, Ontario, Canada.
Zeng
L H
LH
Wu
J
J
Fung
K P
KP
Weisel
R D
RD
Hempel
A
A
Camerman
N
N
D000818:Animals; D000975:Antioxidants / Q000494:pharmacology*; D001567:Benzocycloheptenes / Q000494:pharmacology*; D002478:Cells, Cultured / Q000187:drug effects; D004305:Dose-Response Relationship, Drug; D006352:Heart Ventricles / Q000187:drug effects*; D006801:Humans; D011817:Rabbits; D051381:Rats; D012501:Saphenous Vein / Q000187:drug effects*; D014812:Vitamin K / Q000494:pharmacology
D000975:Antioxidants; D001567:Benzocycloheptenes; D014812:Vitamin K; C026133:purpurogallin